Episurf Medical will present at Redeye Growth Day, a small-cap investor conference, held in Stockholm on June 4 (Haymarket by Scandic, Hötorget 13-15, Stockholm). The event is arranged by Redeye and the company will be represented by CEO Pål Ryfors.
The event be webcasted on https://www.redeye.se/live/growth-day-2018. The presentation will be available on the company’s website after the presentation.
For full program and registration, see link. (https://www.redeye.se/live/growth-day-2018)
For more information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalised treatment alternatives. Episurf Medical’s Episealer® personalised implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.